Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
- PMID: 32699894
- PMCID: PMC7454538
- DOI: 10.1093/eurheartj/ehaa576
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
Figures
Comment on
-
Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?Eur Heart J. 2020 Jul 1;41(32):3092-3093. doi: 10.1093/eurheartj/ehaa509. Eur Heart J. 2020. PMID: 32688380 Free PMC article. No abstract available.
References
-
- Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M.. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020;41:1821–1829. - PMC - PubMed
-
- Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM.. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace 2017;19:1280–1287. - PubMed
-
- Bisbal F, Baranchuk A, Braunwald E, Bayés de Luna A, Bayés-Genís A.. Atrial failure as a clinical entity: JACC Review Topic of the Week. J Am Coll Cardiol 2020;75:222–232. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical